Universitätsklinik Ulm, Neurologie
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Landwehrmeyer, Bernhard
PIVOT-HD, NCT05358717 / 2021-003852-18: A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

Active, not recruiting
2
252
Europe, Canada, US, RoW
PTC518, Placebo
PTC Therapeutics, PTC Therapeutics, Inc.
Huntington Disease
02/25
08/25
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62

Download Options